Almirall acquires US skin medications from Allergan for $550m
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in
Continue reading
Tag: Tazorac
Latest Pharma Industry News
-
Incyte, Innovent announce collaboration for three cancer drugs in China
-
Japanese pharma company Astellas acquires Potenza Therapeutics
-
Amgen scores pediatric FDA approval for Nplate in immune thrombocytopenia
-
Fresenius Kabi launches Omegaven in US for pediatric patients with PNAC
-
Millendo Therapeutics wraps up merger with OvaScience
-
Novartis breast cancer drug Kisqali plus endocrine therapy extends PFS
-
Mirum Pharmaceuticals raises $120m to advance Maralixibat into phase 3
-
Novartis bags Gilenya EC approval for multiple sclerosis in young patients
-
Pfizer, AbbVie resolve IP matters for adalimumab biosimilar
-
EC approves Mundipharma’s Neulasta biosimilar Pelmeg for neutropenia
Business News Today
- PPG to acquire coatings manufacturer Whitford
- Equinor bags new offshore wind lease outside Massachusetts
- Mars Wrigley Confectionery launches Twix Triple Chocolate Cookie Bars
- Montecito Medical acquires medical office buildings in Richmond, VA
- Advantage Capital invests in US residential solar company Momentum Solar
- Nucor acquires Mexican precision castings company POK
- Neustar to acquire authentication and fraud solution firm TRUSTID
- CVRC opens new specialty veterinary hospital in Annapolis, Maryland
- Barrell Craft Spirits launches three limited editions of whiskies and rum
- Dominion’s 1.59GW Greensville County Power Station begins operations
DailyHealthNeeds.com
Did you know eyes can improve mental health
Oral Contraceptives may increase risk of ischemic strokes in women
Health benefits of garlic oil for skin, hair and health problems
Scientists develop nasal spray to treat snoring – sleep apnoea
Surgical menopause increases risk of sleep disorders than natural menopause
